PmcKwd.i
Checkpoint
Pmc
Racine
Checkpoint
Pmc
Exploration
Accueil
Racine
Racine

Serveur d'exploration Tocilizumab - Checkpoint (Pmc)

Index « PmcKwd.i » - entrée « disease activity »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
disease < disease activity < disease assessment  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 11.
Ident.Authors (with country if any)Title
000008 (2020) Emily Liang [États-Unis] ; Mihaela Taylor [États-Unis] ; Maureen Mcmahon [États-Unis]Utility of the AVISE Connective Tissue Disease test in predicting lupus diagnosis and progression
000301 (2020) Judith Sautner [Autriche] ; Rudolf Puchner [Autriche] ; Alois Alkin [Autriche] ; Herwig Pieringer [Royaume-Uni]Depression: a common comorbidity in women with rheumatoid arthritis—results from an Austrian cross-sectional study
000489 (2019) Marta Madej [Pologne] ; Patryk Woytala [Pologne] ; Marek Frankowski [Pologne] ; Łukasz Lubi Ski [Pologne] ; Renata Sokolik [Pologne] ; Agata Sebastian [Pologne] ; Beata Maci Ek-Chyra [Pologne] ; Piotr Wiland [Pologne]Tofacitinib in the treatment of active rheumatoid arthritis – single-centre experience
000601 (2019) Gerd R. Burmester [Allemagne] ; Vibeke Strand [États-Unis] ; Andrea Rubbert-Roth [Suisse] ; Howard Amital [Israël] ; Tatiana Raskina [Russie] ; Antonio G Mez-Centeno [Espagne] ; Claudia Pena-Rossi [États-Unis] ; Leon Gervitz [États-Unis] ; Karthinathan Thangavelu [États-Unis] ; Gregory St John [États-Unis] ; Susan Boklage [États-Unis] ; Mark C. Genovese [États-Unis]Safety and efficacy of switching from adalimumab to sarilumab in patients with rheumatoid arthritis in the ongoing MONARCH open-label extension
000604 (2019) Niels W. Boone [Pays-Bas] ; Alexandre Sepriano [Pays-Bas, Portugal] ; Paul-Hugo Van Der Kuy [Pays-Bas] ; Rob Janknegt [Pays-Bas] ; Ralph Peeters [Pays-Bas] ; Robert B M. Landewé [Pays-Bas]Routine Assessment of Patient Index Data 3 (RAPID3) alone is insufficient to monitor disease activity in rheumatoid arthritis in clinical practice
000839 (2019) Denis Mongin [Suisse] ; Kim Lauper [Suisse] ; Carl Turesson [Suède] ; Merete Lund Hetland [Danemark] ; Eirik Klami Kristianslund [Norvège] ; Tore K. Kvien [Norvège] ; Maria Jose Santos [Portugal] ; Karel Pavelka [République tchèque] ; Florenzo Iannone [Italie] ; Axel Finckh [Suisse] ; Delphine Sophie Courvoisier [Suisse]Imputing missing data of function and disease activity in rheumatoid arthritis registers: what is the best technique?
000942 (2019) Tsutomu Takeuchi [Japon] ; Yoshiya Tanaka [Japon] ; Sakae Tanaka [Japon] ; Atsushi Kawakami [Japon] ; Manabu Iwasaki [Japon] ; Kou Katayama [Japon] ; Mitsuhiro Rokuda [Japon] ; Hiroyuki Izutsu [Japon] ; Satoshi Ushijima [Japon] ; Yuichiro Kaneko [Japon] ; Teruaki Shiomi [Japon] ; Emi Yamada [Japon] ; Désirée Van Der Heijde [Pays-Bas]Efficacy and safety of peficitinib (ASP015K) in patients with rheumatoid arthritis and an inadequate response to methotrexate: results of a phase III randomised, double-blind, placebo-controlled trial (RAJ4) in Japan
000A40 (2019) Alina Alshevskaya ; Julia Lopatnikova ; Julia Zhukova ; Oksana Chumasova ; Nadezhda Shkaruba ; Aleksey Sizikov ; Irina Evsegneeva ; Victor Gladkikh ; Aleksander Karaulov ; Sergey V. Sennikov [Russie]Co-Expression Profile of TNF Membrane-Bound Receptors Type 1 and 2 in Rheumatoid Arthritis on Immunocompetent Cells Subsets
000A85 (2019) Iain B. Mcinnes [Royaume-Uni] ; Gianfranco Ferraccioli [Italie] ; Maria-Antonietta D'Agostino [France] ; Manuela Le Bars [France] ; Subhashis Banerjee [États-Unis] ; Harris A. Ahmad [États-Unis] ; Yedid Elbez [France] ; Philip J. Mease [États-Unis]Body mass index and treatment response to subcutaneous abatacept in patients with psoriatic arthritis: a post hoc analysis of a phase III trial
000B65 (2019) Rinie Geenen [Pays-Bas] ; Emma Dures [Royaume-Uni]A biopsychosocial network model of fatigue in rheumatoid arthritis: a systematic review
000C36 (2018) Fernando Kemta Lekpa [Cameroun] ; Xavier Chevalier [France]Refractory relapsing polychondritis: challenges and solutions

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Pmc/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Checkpoint/PmcKwd.i -k "disease activity" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Checkpoint/PmcKwd.i  \
                -Sk "disease activity" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Checkpoint/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Pmc
   |étape=   Checkpoint
   |type=    indexItem
   |index=    PmcKwd.i
   |clé=    disease activity
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021